April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Lycium Barbarum Polysaccharides Protects Retina From Ischemia/Reperfusion Injury
Author Affiliations & Notes
  • S.-Y. Li
    Eye Institute,
    The University of Hong Kong, Hong Kong, Hong Kong
  • C.-M. Yeung
    Eye Institute,
    The University of Hong Kong, Hong Kong, Hong Kong
  • R.-C. Chang
    Anatomy,
    Research Center of Heart, Brain, Hormone and Healthy Aging,
    The University of Hong Kong, Hong Kong, Hong Kong
  • K.-F. So
    Anatomy,
    Research Center of Heart, Brain, Hormone and Healthy Aging,
    The University of Hong Kong, Hong Kong, Hong Kong
  • D. Wong
    Eye Institute,
    Research Center of Heart, Brain, Hormone and Healthy Aging,
    The University of Hong Kong, Hong Kong, Hong Kong
  • A. C. Lo
    Eye Institute,
    Research Center of Heart, Brain, Hormone and Healthy Aging,
    The University of Hong Kong, Hong Kong, Hong Kong
  • Footnotes
    Commercial Relationships  S.-Y. Li, None; C.-M. Yeung, None; R.-C. Chang, None; K.-F. So, None; D. Wong, None; A.C. Lo, None.
  • Footnotes
    Support  University Development Fund from The University of Hong Kong
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4707. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.-Y. Li, C.-M. Yeung, R.-C. Chang, K.-F. So, D. Wong, A. C. Lo; Lycium Barbarum Polysaccharides Protects Retina From Ischemia/Reperfusion Injury. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4707.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal ischemia/reperfusion (I/R) injury leads to irreversible damage to retinal neurons and structures. It is common in various ocular complications, such as glaucoma, diabetic retinopathy and retinal vessel occlusion. In the present study, we aimed to evaluate the effects of Lycium barbarum polysaccharides (LBP), a traditional Chinese medicine, in a mouse model of retinal I/R injury.

Methods: : Adult C57/BL6N mice were orally treated with either vehicle (PBS) or LBP (1 mg/kg or 10 mg/kg once daily) for 1 week before induction of retinal ischemia by the intraluminal suture method. After 2 hours of retinal ischemia followed by 22 hours of reperfusion, retinae were immediately harvested, fixed, and paraffin-embedded for subsequent histological and immunohistochemical analyses. Morphological changes, cell counting and retinal thickness were assessed on hematoxylin and eosin-stained retinal sections. Apoptosis was determined using TUNEL assay and number of apoptotic cells was counted. Blood vessel leakage indicated by IgG extravasations was quantified. Glial fibrillary acidic protein (GFAP) immunohistochemistry was performed.

Results: : Significantly fewer viable cells were found in the ganglion cell layer (GCL) of vehicle-treated retinae after retinal I/R injury. However, LBP treatment yielded more viable cells and fewer dead cells in GCL. This finding of less neuronal cell death in LBP-treated groups was further confirmed by TUNEL assay where significantly fewer apoptotic cells were identified. In addition, the significant retinal swelling induced by retinal I/R injury in the vehicle-treated group was not observed in LBP-treated groups. Moreover, intense GFAP immunoreactivity and IgG extravasations were observed in vehicle-treated group but not in LBP treated groups.

Conclusions: : Our data indicate that pre-treatment with LBP could protect the retina from retinal I/R damage via reducing neuronal cell death, apoptosis, retinal swelling, GFAP activation and blood vessel leakage. These suggest that LBP may be used as a preventive medicine for retinal ischemia.

Keywords: retina • ganglion cells • apoptosis/cell death 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×